C/J/C + IPAMO

CJC-1295 / Ipamorelin is a dual-peptide research blend combining a growth hormone releasing hormone (GHRH) analog with a selective growth hormone secretagogue. Preclinical research has explored this combination for its effects on growth hormone pulse amplification, IGF-1 pathway activity, metabolic regulation, and lean body composition across controlled in-vitro and in-vivo research models.

The lyophilized preparation enables accurate laboratory reconstitution using sterile handling techniques. Consistent preparation methods and appropriate storage conditions help maintain compound stability and improve reproducibility during extended research cycles.

Product Specifications

• Form: Lyophilized powder
• Amount: 5mg CJC-1295 / 5mg Ipamorelin per vial
• Purity: ≥99% — COA available
• Testing: Third-party tested for identity and purity
• CAS Number (CJC-1295): 863288-34-0
• CAS Number (Ipamorelin): 170851-70-4
• Storage: -20°C, protected from light and moisture
• Stability: Stable 24 months when stored properly

For research purposes only. Not for human or animal use & not FDA-approved. By purchasing, you confirm you are 21 or older and a qualified researcher.

This product has not been evaluated by the FDA and is not intended to diagnose, treat, cure, or prevent any disease.

Researchers should follow all applicable regulations and institutional guidelines when handling this compound.

By purchasing, you confirm you are 21 years of age or older and a qualified researcher.

For research purposes only. Not for human or animal use.